Logo image of JEN.DE

JENOPTIK AG (JEN.DE) Stock Fundamental Analysis

FRA:JEN - DE000A2NB601 - Common Stock

16.17 EUR
-0.14 (-0.86%)
Last: 9/10/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to JEN. JEN was compared to 50 industry peers in the Electronic Equipment, Instruments & Components industry. While JEN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. JEN has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year JEN was profitable.
JEN had a positive operating cash flow in the past year.
JEN had positive earnings in each of the past 5 years.
Each year in the past 5 years JEN had a positive operating cash flow.
JEN.DE Yearly Net Income VS EBIT VS OCF VS FCFJEN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.67%, JEN is in the better half of the industry, outperforming 76.00% of the companies in the same industry.
With a decent Return On Equity value of 8.08%, JEN is doing good in the industry, outperforming 76.00% of the companies in the same industry.
With a decent Return On Invested Capital value of 6.34%, JEN is doing good in the industry, outperforming 76.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for JEN is in line with the industry average of 6.96%.
Industry RankSector Rank
ROA 4.67%
ROE 8.08%
ROIC 6.34%
ROA(3y)4.32%
ROA(5y)4.15%
ROE(3y)8.12%
ROE(5y)8.24%
ROIC(3y)7.15%
ROIC(5y)6.58%
JEN.DE Yearly ROA, ROE, ROICJEN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

Looking at the Profit Margin, with a value of 7.21%, JEN belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
JEN's Profit Margin has been stable in the last couple of years.
JEN has a Operating Margin of 11.41%. This is amongst the best in the industry. JEN outperforms 86.00% of its industry peers.
In the last couple of years the Operating Margin of JEN has grown nicely.
JEN has a worse Gross Margin (32.28%) than 68.00% of its industry peers.
In the last couple of years the Gross Margin of JEN has remained more or less at the same level.
Industry RankSector Rank
OM 11.41%
PM (TTM) 7.21%
GM 32.28%
OM growth 3Y-1.94%
OM growth 5Y5.73%
PM growth 3Y-8.73%
PM growth 5Y0.97%
GM growth 3Y0.54%
GM growth 5Y0.38%
JEN.DE Yearly Profit, Operating, Gross MarginsJEN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so JEN is still creating some value.
JEN has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for JEN remains at a similar level compared to 5 years ago.
The debt/assets ratio for JEN has been reduced compared to a year ago.
JEN.DE Yearly Shares OutstandingJEN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
JEN.DE Yearly Total Debt VS Total AssetsJEN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

JEN has an Altman-Z score of 2.36. This is not the best score and indicates that JEN is in the grey zone with still only limited risk for bankruptcy at the moment.
JEN's Altman-Z score of 2.36 is in line compared to the rest of the industry. JEN outperforms 50.00% of its industry peers.
JEN has a debt to FCF ratio of 6.46. This is a slightly negative value and a sign of low solvency as JEN would need 6.46 years to pay back of all of its debts.
JEN's Debt to FCF ratio of 6.46 is in line compared to the rest of the industry. JEN outperforms 52.00% of its industry peers.
A Debt/Equity ratio of 0.33 indicates that JEN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.33, JEN is in line with its industry, outperforming 58.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 6.46
Altman-Z 2.36
ROIC/WACC1.14
WACC5.57%
JEN.DE Yearly LT Debt VS Equity VS FCFJEN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

JEN has a Current Ratio of 1.62. This is a normal value and indicates that JEN is financially healthy and should not expect problems in meeting its short term obligations.
JEN has a Current ratio (1.62) which is comparable to the rest of the industry.
JEN has a Quick Ratio of 1.62. This is a bad value and indicates that JEN is not financially healthy enough and could expect problems in meeting its short term obligations.
JEN has a Quick ratio of 0.80. This is in the lower half of the industry: JEN underperforms 74.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 0.8
JEN.DE Yearly Current Assets VS Current LiabilitesJEN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

The earnings per share for JEN have decreased by -3.57% in the last year.
The Earnings Per Share has been growing slightly by 6.54% on average over the past years.
The Revenue has decreased by -2.59% in the past year.
Measured over the past years, JEN shows a small growth in Revenue. The Revenue has been growing by 5.46% on average per year.
EPS 1Y (TTM)-3.57%
EPS 3Y4.03%
EPS 5Y6.54%
EPS Q2Q%-38.1%
Revenue 1Y (TTM)-2.59%
Revenue growth 3Y14.12%
Revenue growth 5Y5.46%
Sales Q2Q%-10.49%

3.2 Future

The Earnings Per Share is expected to grow by 9.81% on average over the next years. This is quite good.
JEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.76% yearly.
EPS Next Y-16.59%
EPS Next 2Y5.28%
EPS Next 3Y7.62%
EPS Next 5Y9.81%
Revenue Next Year-3.99%
Revenue Next 2Y1.14%
Revenue Next 3Y2.9%
Revenue Next 5Y3.76%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
JEN.DE Yearly Revenue VS EstimatesJEN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
JEN.DE Yearly EPS VS EstimatesJEN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

JEN is valuated reasonably with a Price/Earnings ratio of 11.98.
88.00% of the companies in the same industry are more expensive than JEN, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of JEN to the average of the S&P500 Index (27.03), we can say JEN is valued rather cheaply.
JEN is valuated reasonably with a Price/Forward Earnings ratio of 9.00.
Based on the Price/Forward Earnings ratio, JEN is valued a bit cheaper than 80.00% of the companies in the same industry.
JEN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.54.
Industry RankSector Rank
PE 11.98
Fwd PE 9
JEN.DE Price Earnings VS Forward Price EarningsJEN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

JEN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. JEN is cheaper than 64.00% of the companies in the same industry.
JEN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 13.44
EV/EBITDA 6.59
JEN.DE Per share dataJEN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

JEN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.83
EPS Next 2Y5.28%
EPS Next 3Y7.62%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.34%, JEN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.87, JEN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.45, JEN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.34%

5.2 History

Dividend Growth(5Y)0%
Div Incr Years0
Div Non Decr Years0
JEN.DE Yearly Dividends per shareJEN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2025 0.1 0.2 0.3

5.3 Sustainability

28.10% of the earnings are spent on dividend by JEN. This is a low number and sustainable payout ratio.
DP28.1%
EPS Next 2Y5.28%
EPS Next 3Y7.62%
JEN.DE Yearly Income VS Free CF VS DividendJEN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
JEN.DE Dividend Payout.JEN.DE Dividend Payout, showing the Payout Ratio.JEN.DE Dividend Payout.PayoutRetained Earnings

JENOPTIK AG

FRA:JEN (9/10/2025, 7:00:00 PM)

16.17

-0.14 (-0.86%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-12 2025-11-12
Inst Owners40.07%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap925.57M
Analysts83.75
Price Target25.12 (55.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.34%
Yearly Dividend0.35
Dividend Growth(5Y)0%
DP28.1%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.43%
Min EPS beat(2)-20.99%
Max EPS beat(2)-5.88%
EPS beat(4)2
Avg EPS beat(4)-2.09%
Min EPS beat(4)-20.99%
Max EPS beat(4)13.86%
EPS beat(8)3
Avg EPS beat(8)-6.27%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.06%
Min Revenue beat(2)-3.34%
Max Revenue beat(2)-2.79%
Revenue beat(4)0
Avg Revenue beat(4)-2.77%
Min Revenue beat(4)-3.34%
Max Revenue beat(4)-1.93%
Revenue beat(8)1
Avg Revenue beat(8)-6.15%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.47%
PT rev (3m)-4.8%
EPS NQ rev (1m)-3.79%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-20.62%
EPS NY rev (3m)-20.62%
Revenue NQ rev (1m)-2.91%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.19%
Revenue NY rev (3m)-4.16%
Valuation
Industry RankSector Rank
PE 11.98
Fwd PE 9
P/S 0.86
P/FCF 13.44
P/OCF 5.65
P/B 0.97
P/tB 3.32
EV/EBITDA 6.59
EPS(TTM)1.35
EY8.35%
EPS(NY)1.8
Fwd EY11.11%
FCF(TTM)1.2
FCFY7.44%
OCF(TTM)2.86
OCFY17.7%
SpS18.75
BVpS16.74
TBVpS4.87
PEG (NY)N/A
PEG (5Y)1.83
Profitability
Industry RankSector Rank
ROA 4.67%
ROE 8.08%
ROCE 9.24%
ROIC 6.34%
ROICexc 6.61%
ROICexgc 14.19%
OM 11.41%
PM (TTM) 7.21%
GM 32.28%
FCFM 6.42%
ROA(3y)4.32%
ROA(5y)4.15%
ROE(3y)8.12%
ROE(5y)8.24%
ROIC(3y)7.15%
ROIC(5y)6.58%
ROICexc(3y)7.54%
ROICexc(5y)6.96%
ROICexgc(3y)16.1%
ROICexgc(5y)15.71%
ROCE(3y)10.41%
ROCE(5y)9.58%
ROICexcg growth 3Y-2.02%
ROICexcg growth 5Y2.07%
ROICexc growth 3Y7.18%
ROICexc growth 5Y-3.9%
OM growth 3Y-1.94%
OM growth 5Y5.73%
PM growth 3Y-8.73%
PM growth 5Y0.97%
GM growth 3Y0.54%
GM growth 5Y0.38%
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 6.46
Debt/EBITDA 1.6
Cap/Depr 124.4%
Cap/Sales 8.85%
Interest Coverage 7.67
Cash Conversion 82.4%
Profit Quality 88.97%
Current Ratio 1.62
Quick Ratio 0.8
Altman-Z 2.36
F-Score4
WACC5.57%
ROIC/WACC1.14
Cap/Depr(3y)121.37%
Cap/Depr(5y)106.88%
Cap/Sales(3y)8.22%
Cap/Sales(5y)7.57%
Profit Quality(3y)101.44%
Profit Quality(5y)95.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.57%
EPS 3Y4.03%
EPS 5Y6.54%
EPS Q2Q%-38.1%
EPS Next Y-16.59%
EPS Next 2Y5.28%
EPS Next 3Y7.62%
EPS Next 5Y9.81%
Revenue 1Y (TTM)-2.59%
Revenue growth 3Y14.12%
Revenue growth 5Y5.46%
Sales Q2Q%-10.49%
Revenue Next Year-3.99%
Revenue Next 2Y1.14%
Revenue Next 3Y2.9%
Revenue Next 5Y3.76%
EBIT growth 1Y-10.03%
EBIT growth 3Y11.91%
EBIT growth 5Y11.51%
EBIT Next Year46.8%
EBIT Next 3Y21.91%
EBIT Next 5Y14.54%
FCF growth 1Y-0.61%
FCF growth 3Y12.68%
FCF growth 5Y2.87%
OCF growth 1Y7.73%
OCF growth 3Y19.51%
OCF growth 5Y8.88%